No Data
No Data
Is It Worth Considering Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SZSE:301234) For Its Upcoming Dividend?
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be intrigued to know that Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SZSE:3012
Wuzhou Medical (301234.SZ) has been granted a patent for an intelligent, wearable, precision injector with delayed release.
On June 18th, Gelunhui reported that Wuzhou Medical (301234.SZ) obtained an invention patent certificate from the State Intellectual Property Office on June 18, 2024. The company's medical equipment product, "An intelligent wearable precision injector with delayed effect", has obtained the patent authorization. The product covered by this patent authorization is in the field of medical equipment technology. It is an innovative patch injection system designed to automatically deliver large doses or high viscosity biotech drugs subcutaneously in home or clinical environments. Its feature is that it can be done in seconds to a few minutes.
Wuzhou Medical (301234.SZ): Annual equity distribution for 2023 is 10 shares of 4 yuan. The record date for equity is June 24.
Wuzhou Medical (301234.SZ) announced on June 17th that the annual equity distribution plan for 2023 is to distribute cash dividends of RMB 4.00 (tax included) per 10 shares to all shareholders based on the current total share capital of 68,000,000 shares. The registration date for stock rights is June 24, 2024, and the ex-dividend date is June 25, 2024.
Wuzhou Healthcare (301234.SZ): Currently not cooperating with Eli Lilly's tipotide products
Gelonghui, May 23 | Wuzhou Medical (301234.SZ) said on the investor interactive platform that the company specializes in R&D, manufacturing and sales of disposable sterile infusion medical devices. The main products include syringes, blood transfusions, medical puncture needles, and other diagnostic and clinical care products. The company is currently not cooperating with Lilly's Tirzepatide (Tirzepatide) products.
Why Anhui Hongyu Wuzhou Medical ManufacturerLTD's (SZSE:301234) Shaky Earnings Are Just The Beginning Of Its Problems
The market wasn't impressed with the soft earnings from Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SZSE:301234) recently. We did some analysis, and found that there are some reasons to be cau
Wuzhou Healthcare (301234.SZ): Director and executive Pan Lanlan completed an increase of 212,000 shares
Gelonghui, Feb. 23 | Wuzhou Healthcare (301234.SZ) announced that as of February 23, 2024, the plan to increase shareholding has been completed. Ms. Pan Lanlan, director of the company, secretary of the board of directors, and deputy general manager, increased her holdings of the company by a total of 212,000 shares, accounting for 0.0312% of the company's total share capital, with an increase of 5010,000 yuan (RMB).
No Data